Stuart Abel
About Stuart Abel
Stuart Abel serves as the Global Head of Regulatory Affairs at Evelo Biosciences, a position he has held since 2019. He has extensive experience in regulatory affairs, having previously worked at notable companies such as Pfizer, Genzyme, and Forest Laboratories Europe.
Work at Evelo Biosciences
Stuart Abel has been serving as the Global Head of Regulatory Affairs at Evelo Biosciences since 2019. In this role, he oversees the regulatory strategies and compliance for the company, which focuses on developing innovative therapies based on the microbiome. His leadership in regulatory affairs is crucial for navigating the complex landscape of drug development and ensuring that Evelo's products meet all regulatory requirements.
Previous Experience in Regulatory Affairs
Before joining Evelo Biosciences, Stuart Abel held several significant positions in regulatory affairs. He worked at Pfizer as Director & Global Regulatory Leader from 1998 to 2005. He also served as VP of Regulatory Affairs at Genzyme from 2010 to 2012 and as VP of Global Regulatory Affairs at The Medicines Company from 2008 to 2010. Additionally, he was the Head of Regulatory Affairs at Forest Laboratories Europe from 2012 to 2015 and worked as an Advisor in Strategic Regulatory Affairs at SFL Regulatory Affairs & Scientific Communication Ltd from 2016 to 2019.
Education and Expertise
Stuart Abel studied at the University of Liverpool, where he earned both a BSc and a PhD in Chemistry and Pharmacology from 1987 to 1993. His educational background provides a strong foundation for his extensive career in regulatory affairs, equipping him with the knowledge necessary to navigate the scientific and regulatory complexities of the pharmaceutical industry.
Current Role at SUMMIT REGULATORY SERVICES LTD
In addition to his role at Evelo Biosciences, Stuart Abel has been the Director at SUMMIT REGULATORY SERVICES LTD since 2015. His responsibilities include providing strategic regulatory guidance and support to clients in the pharmaceutical sector, leveraging his extensive experience in regulatory affairs to facilitate successful product development and approval processes.